This protocol details a facile, one-pot synthesis of manganese oxide (MnO) nanoparticles by thermal decomposition of manganese(II) acetylacetonate in the presence of oleylamine and dibenzyl ether. MnO nanoparticles have been utilized in diverse applications including magnetic resonance imaging, biosensing, catalysis, batteries, and waste water treatment.
For biomedical applications, metal oxide nanoparticles such as iron oxide and manganese oxide (MnO), have been used as biosensors and contrast agents in magnetic resonance imaging (MRI). While iron oxide nanoparticles provide constant negative contrast on MRI over typical experimental timeframes, MnO generates switchable positive contrast on MRI through dissolution of MnO to Mn2+ at low pH within cell endosomes to ‘turn ON’ MRI contrast. This protocol describes a one-pot synthesis of MnO nanoparticles formed by thermal decomposition of manganese(II) acetylacetonate in oleylamine and dibenzyl ether. Although running the synthesis of MnO nanoparticles is simple, the initial experimental setup can be difficult to reproduce if detailed instructions are not provided. Thus, the glassware and tubing assembly is first thoroughly described to allow other investigators to easily reproduce the setup. The synthesis method incorporates a temperature controller to achieve automated and precise manipulation of the desired temperature profile, which will impact resulting nanoparticle size and chemistry. The thermal decomposition protocol can be readily adapted to generate other metal oxide nanoparticles (e.g., iron oxide) and to include alternative organic solvents and stabilizers (e.g., oleic acid). In addition, the ratio of organic solvent to stabilizer can be changed to further impact nanoparticle properties, which is shown herein. Synthesized MnO nanoparticles are characterized for morphology, size, bulk composition, and surface composition through transmission electron microscopy, X-ray diffraction, and Fourier-transform infrared spectroscopy, respectively. The MnO nanoparticles synthesized by this method will be hydrophobic and must be further manipulated through ligand exchange, polymeric encapsulation, or lipid capping to incorporate hydrophilic groups for interaction with biological fluids and tissues.
Metal oxide nanoparticles possess magnetic, electric, and catalytic properties, which have been applied in bioimaging1,2,3, sensor technologies4,5, catalysis6,7,8, energy storage9, and water purification10. Within the biomedical field, iron oxide nanoparticles and manganese oxide (MnO) nanoparticles have proven utility as contrast agents in magnetic resonance imaging (MRI)1,2. Iron oxide nanoparticles produce robust negative contrast on T2* MRI and are powerful enough to visualize single labeled cells in vivo11,12,13; however, the negative MRI signal cannot be modulated and remains “ON” throughout the duration of typical experiments. Due to endogenous iron present in the liver, bone marrow, blood and spleen, the negative contrast generated from iron oxide nanoparticles may be difficult to interpret. MnO nanoparticles, on the other hand, are responsive to a drop in pH. MRI signal for MnO nanoparticles can transition from “OFF” to “ON” once the nanoparticles are internalized inside the low pH endosomes and lysosomes of the target cell such as a cancer cell14,15,16,17,18,19. The positive contrast on T1 MRI produced from the dissolution of MnO to Mn2+ at low pH is unmistakable and can improve cancer detection specificity by only lighting up at the target site within a malignant tumor. Control over nanoparticle size, morphology and composition is crucial to achieve maximum MRI signal from MnO nanoparticles. Herein, we describe how to synthesize and characterize MnO nanoparticles using the thermal decomposition method and note different strategies for fine-tuning nanoparticle properties by altering variables in the synthesis process. This protocol can be easily modified to produce other magnetic nanoparticles such as iron oxide nanoparticles.
MnO nanoparticles have been produced by a variety of techniques including thermal decomposition20,21,22,23,24,25, hydro/solvothermal26,27,28,29, exfoliation30,31,32,33,34, permanganates reduction35,36,37,38, and adsorption-oxidation39,40,41,42. Thermal decomposition is the most commonly used technique which involves dissolving manganese precursors, organic solvents, and stabilizing agents at high temperatures (180 – 360 °C) under the presence of an inert gaseous atmosphere to form MnO nanoparticles43. Out of all of these techniques, thermal decomposition is the superior method to generate a variety of MnO nanocrystals of pure phase (MnO, Mn3O4 and Mn2O3) with a narrow size distribution. Its versatility is highlighted through the ability to tightly control nanoparticle size, morphology and composition by altering reaction time44,45,46, temperature44,47,48,49, types/ratios of reactants20,45,47,48,50 and inert gas47,48,50 used. The main limitations of this method are the requirement for high temperatures, the oxygen-free atmosphere, and the hydrophobic coating of the synthesized nanoparticles, which requires further modification with polymers, lipids or other ligands to increase solubility for biological applications14,51,52,53.
Besides thermal decomposition, the hydro/solvothermal method is the only other technique that can produce a variety of MnO phases including MnO, Mn3O4, and MnO2; all other strategies only form MnO2 products. During hydro/solvothermal synthesis, precursors such as Mn(II) stearate54,55 and Mn(II) acetate27 are heated to between 120-200 °C over several hours to achieve nanoparticles with a narrow size distribution; however, specialized reaction vessels are required and reactions are performed at high pressures. In contrast, the exfoliation strategy involves treatment of a layered or bulk material to promote dissociation into 2D single layers. Its main advantage is in producing MnO2 nanosheets, but the synthesis process is long requiring several days and the resulting size of the sheets is difficult to control. Alternatively, permanganates such as KMnO4 can react with reducing agents such as oleic acid56,57, graphene oxide58 or poly(allylamine hydrochloride)59 to create MnO2 nanoparticles. Use of KMnO4 facilitates nanoparticle formation at room temperature over a few minutes to hours within aqueous conditions43. Unfortunately, the rapid synthesis and nanoparticle growth makes it challenging to finely control resulting nanoparticle size. MnO2 nanoparticles can also be synthesized using adsorption-oxidation whereby Mn2+ ions are adsorbed and oxidized to MnO2 by oxygen under basic conditions. This method will produce small MnO2 nanoparticles with a narrow size distribution at room temperature over several hours in aqueous media; however the requirement for adsorption of Mn2+ ions and alkali conditions limits its widespread application43.
Of the MnO nanoparticle synthesis methods discussed, thermal decomposition is the most versatile to generate different monodisperse pure phase nanocrystals with control over nanoparticle size, shape and composition without requiring specialized synthesis vessels. In this manuscript, we describe how to synthesize MnO nanoparticles by thermal decomposition at 280 °C using manganese(II) acetylacetonate (Mn(II) ACAC) as the source of Mn2+ ions, oleylamine (OA) as the reducing agent and stabilizer, and dibenzyl ether (DE) as the solvent under a nitrogen atmosphere. The glassware and tubing setup for nanoparticle synthesis is explained in detail. One advantage of the technique is the inclusion of a temperature controller, thermocouple probe, and heating mantle to enable precise control over the heating rate, peak temperature, and reaction times at each temperature to fine-tune nanoparticle size and composition. Herein, we show how nanoparticle size can also be manipulated by changing the ratio of OA to DE. Additionally, we demonstrate how to prepare nanoparticle samples and measure nanoparticle size, bulk composition and surface composition using transmission electron microscopy (TEM), x-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR), respectively. Further guidance is included on how to analyze the collected images and spectra from each instrument. To generate uniformly shaped MnO nanoparticles, a stabilizer and adequate nitrogen flow must be present; XRD and TEM results are shown for undesired products formed in the absence of OA and under low nitrogen flow. In the Discussion section, we highlight crucial steps in the protocol, metrics to determine successful nanoparticle synthesis, further variation of the decomposition protocol to modify nanoparticle properties (size, morphology and composition), troubleshooting and limitations of the method, and applications of MnO nanoparticles as contrast agents for biomedical imaging.
The protocol herein describes a facile, one-pot synthesis of MnO nanoparticles using Mn(II) ACAC, DE, and OA. Mn(II) ACAC is utilized as the starting material to provide a source of Mn2+ for MnO nanoparticle formation. The starting material can be easily substituted to enable production of other metal oxide nanoparticles. For example, when iron(III) ACAC is applied, Fe3O4 nanoparticles can be generated using the same nanoparticle synthesis equipment and protocol described<sup class="xref"…
The authors have nothing to disclose.
This work was supported by WVU Chemical and Biomedical Engineering Department startup funds (M.F.B.). The authors would like to thank Dr. Marcela Redigolo for guidance on grid preparation and image capture of nanoparticles with TEM, Dr. Qiang Wang for support on evaluating XRD and FTIR spectra, Dr. John Zondlo and Hunter Snoderly for programming and integrating the temperature controller into the nanoparticle synthesis protocol, James Hall for his assistance in assembly of the nanoparticle synthesis setup, Alexander Pueschel and Jenna Vito for aiding in quantification of MnO nanoparticle diameters from TEM images, and the WVU Shared Research Facility for use of the TEM, XRD, and FTIR.
Chemicals and Gases | |||
Benzyl ether (DE) | Acros Organics | AC14840-0010 | Concentration: 99%, 1 L |
Drierite | W. A. Hammond Drierite Co. LTD | 23001 | Drierite 8 mesh, 1 lb |
Ethanol | Decon Laboratories | 2701 | 200 proof, 4 x 3.7 L |
Hexane | Macron Fine Chemicals | 5189-08 | Concentration: ≥98.5%, 4 L |
Hydrochloric acid | VWR | BDH3030-2.5LPC | Concentration: 36.5 – 38.0 % ACS, 2.5 L |
Manganese (II) acetyl acetonate (Mn(II)ACAC) | Sigma Aldrich | 245763-100G | 100 g |
Nitrogen gas tank | Airgas | NI R300 | Research 5.7 grade nitrogen, size 300 cylinder |
Nitrogen regulator | Airgas | Y11244D580-AG | Single stage brass 0-100 psi analytical cylinder regulator CGA-580 with needle outlet |
Oleylamine (OA) | Sigma Aldrich | O7805-500G | Concentration: 70%, technical grade, 500 g |
Silicone oil | Beantown Chemical | 221590-100G | 100 g |
Equipment | |||
Centrifuge | Beckman-Coulter | Avanti J-E | JA-20 fixed-angle aluminum rotor, 8 x 50 mL, 48,400 x g |
Hemisphere mantle | Ace Glass Inc. | 12035-17 | 115 V, 270 W, 500 mL, temperature up to 450 °C |
Hot plate stirrer | VWR | 97042-642 | 120 V, 1000 W, 8.3 A, ceramic top |
Temperature controller | Yokogawa Electric Corporation | UP351 | |
Temperature probe | Omega | KMQXL-040G-12 | Immersion probe, temperature up to 1335 °C |
Vacuum oven | Fisher Scientific | 282A | 120 V, 1800 W, temperature up to 280 °C |
Vortex mixer | Fisher Scientific | 02-215-365 | 120 V, 50/60 Hz, 150 W |
Water bath sonicator | Fisher Scientific | FS30H | Ultrasonic power 130 W, 3.7 L tank |
Tools and Materials | |||
Dumont tweezer | Electron Microscopy Sciences | 72703D | Style 5/45, Dumoxel, 109 mm, for picking up TEM grids |
Dumont reverse tweezer | Ted Pella | 5748 | Style N2a, 118 mm, NM-SS, self-closing, holding TEM grids in place for sample preparation |
Mortar and pestle | Amazon | BS0007 | BIPEE agate mortar and pestle, 70 X 60 X 15 mm labware |
Nalgene™ Oak Ridge tubes | ThermoFisher Scientific | 3139-0050 | Polypropylene copolymer, 50,000 x g, 50 mL, pack of 10 |
Scintillation vials | Fisher Scientific | 03-337-4 | 20 mL vials with white caps, case of 500 |
TEM grids | Ted Pella | 01813-F | Carbon Type-B, 300 mesh, copper, pack of 50 |
Glassware Setup | |||
4-neck round bottom flask | Chemglass Life Sciences | CG-1534-01 | 24/40 joint, 500 mL, #7 chem thread for thermometers |
6-port vacuum manifold | Chemglass Life Sciences | CG-4430-02 | 480 nm, 6 ports, 4 mm PTFE stopcocks |
Adapter | Chemglass Life Sciences | CG-1014-01 | 24/40 inner joint, 90° |
Condenser | Chemglass Life Sciences | CG-1216-03 | 24/40 joint, 365 mm, 250 mm jacket length |
Drierite 26800 drying column | Cole-Parmer | EW-07193-00 | 200 L/hr, 90 psi |
Funnel | Chemglass Life Sciences | CG-1720-L-02 | 24/40 joint, 100 powder funnel, 195 mm OAL |
Interlocked worm gear hose clamp | Grainger | 16P292 | 1/2" wide stainless steel clamp, 3/8" to 7/8" diameter, to secure condenser tubing, 10 pack |
Keck clips | Kemtech America Inc | CS002440 | 24/40 joint |
Metal claw clamp | Fisher Scientific | 05-769-7Q | 22cm, three-prong extension clamps |
Metal claw clamp holder | Fisher Scientific | 05-754Q | Clamp regular holder |
Mineral oil bubbler | Kemtech America Inc | B257040 | 185 mm |
Rotovap trap | Chemglass Life Sciences | CG-1319-02 | 24/40 joints, 100 mL, self washing rotary evaporator |
Rubber stopper | Chemglass Life Sciences | CG-3022-98 | 24/40 joints, red rubber |
Tubing for air/water | McMaster-Carr | 6516T21 | Clear Tygon PVC for air/water, B-44-3, 1/4" ID, 1/16" wall, 25 ft |
Tubing for air/water | McMaster-Carr | 6516T26 | Clear Tygon PVC for air/water, B-44-3, 3/8" ID, 1/16" wall, 25 ft |
Tubing for chemicals | McMaster-Carr | 5155T34 | Clear Tygon PVC for chemicals, E-3603, 3/8" ID, 1/16" wall, 50 ft |
Analysis Programs | |||
XRD analysis program | Malvern Panalytical | N/A | X'Pert HighScore Plus |
FTIR analysis program | Varian, Inc. | N/A | Varian Resolutions Pro |